StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Interpace Biosciences's pe ratio was 5.6× on Oct 19, 2026, against 1.0× a year earlier. Over the last 2 years it ranged from 0.4× to 8.5×, with a median of 2.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20265.6×+4.2
2025Dec 31, 20251.4×−0.6
2024Dec 31, 20242.0×–

More Interpace Biosciences figures

See a number that looks wrong?